StockNews.com Downgrades Tactile Systems Technology (NASDAQ:TCMD) to Buy

StockNews.com lowered shares of Tactile Systems Technology (NASDAQ:TCMDFree Report) from a strong-buy rating to a buy rating in a research note released on Monday morning.

Several other equities analysts also recently commented on the stock. B. Riley began coverage on shares of Tactile Systems Technology in a report on Thursday, September 26th. They issued a “buy” rating and a $23.00 target price on the stock. Oppenheimer downgraded shares of Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a report on Tuesday, November 5th. Finally, BTIG Research downgraded shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a report on Tuesday, November 5th.

View Our Latest Analysis on Tactile Systems Technology

Tactile Systems Technology Price Performance

TCMD stock opened at $18.93 on Monday. Tactile Systems Technology has a one year low of $11.12 and a one year high of $21.10. The company’s fifty day moving average price is $15.04 and its 200-day moving average price is $13.47. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.80 and a current ratio of 4.37. The company has a market capitalization of $454.32 million, a PE ratio of 29.12 and a beta of 1.17.

Institutional Investors Weigh In On Tactile Systems Technology

Large investors have recently bought and sold shares of the business. Arcadia Investment Management Corp MI bought a new stake in Tactile Systems Technology in the third quarter worth $29,000. Gladius Capital Management LP bought a new stake in Tactile Systems Technology in the third quarter worth $44,000. Quarry LP bought a new stake in Tactile Systems Technology in the second quarter worth $46,000. Magnetar Financial LLC bought a new position in Tactile Systems Technology during the second quarter valued at $130,000. Finally, SG Americas Securities LLC bought a new position in Tactile Systems Technology during the third quarter valued at $156,000. Institutional investors own 83.43% of the company’s stock.

About Tactile Systems Technology

(Get Free Report)

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.

See Also

Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.